STUDY OF LIPOSOME ENCAPSULATED MONOACETATE GLYCOLYSIS INHIBITOR AS AN ANTITUMOR AGENT IN A LEWIS LUNG CARCINOMA MODEL

2020 ◽  
Vol 18 (6) ◽  
Author(s):  
E.E. Buyko ◽  
D.A. Korshunov ◽  
I.V. Kondakova
Keyword(s):  
Lung Carcinoma ◽  
Lewis Lung Carcinoma ◽  
Antitumor Agent ◽  
Lewis Lung ◽  
Lewis Lung Carcinoma Model ◽  
Glycolysis Inhibitor

scholarly journals YL4073 is a potent autophagy-stimulating antitumor agent in an in vivo model of Lewis lung carcinoma

2016 ◽  
Vol 35 (4) ◽  
pp. 2081-2088 ◽  
Author(s):  
YOU-ZHI XU ◽  
YONG-HUAI LI ◽  
WEN-JIE LU ◽  
KUN LU ◽  
CHUN-TING WANG ◽  
...  
Keyword(s):  
Lung Carcinoma ◽  
Lewis Lung Carcinoma ◽  
Antitumor Agent ◽  
In Vivo Model ◽  
Lewis Lung

scholarly journals Novel pyrazolopyrimidine derivatives inhibit angiogenesis and tumor growth in a mouse Lewis lung carcinoma model

2015 ◽  
Vol 26 ◽  
pp. ii36 ◽  
Author(s):  
M. Michailidou ◽  
V. Giannouli ◽  
I. Kostakis ◽  
V. Kotsikoris ◽  
P. Marakos ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Lung Carcinoma ◽  
Lewis Lung Carcinoma ◽  
Lewis Lung ◽  
Lewis Lung Carcinoma Model

scholarly journals P2.01-091 The Anticancer Effect of Techoic Acids on Lewis Lung Carcinoma Model

2017 ◽  
Vol 12 (1) ◽  
pp. S843-S844 ◽  
Author(s):  
Viktoriia Nikulina ◽  
Liudmyla Garmanchuk ◽  
Tetiana Nikolaienko ◽  
Natalia Senchylo
Keyword(s):  
Lung Carcinoma ◽  
Lewis Lung Carcinoma ◽  
Lewis Lung ◽  
Anticancer Effect ◽  
Lewis Lung Carcinoma Model
Sign in / Sign up

Export Citation Format

Share Document